Newcastle scientists are part of a multi-million pound investment for digital pathology, radiology and artificial intelligence schemes to improve patient diagnosis.
NGS and targeting the DNA damage response in Cancer
This two-day course will provide an introduction to Next Generation Sequencing with a focus on targeting DNA repair defects. The course will be delivered through lectures and practical laboratory sessions at the Centre for Life in Newcastle Upon Tyne.
In 2018/19, there are four Node bursaries available each worth £2,610 to contribute towards your tuition fees for our new MSc Clinical Health Sciences with Molecular Pathology Programme.
More information about the course, including details on how to apply, can be found here: http://www.ncl.ac.uk/postgraduate/courses/degrees/clinical-healthsciences-molecularpathology/#profile
How to Apply for Funding
Online graduate Zeeshan, writes about his e-learning experience:
I am currently (2017) an Assistant Professor of Molecular Pathology in the Department of Pathology and Laboratory Medicine at the Aga Khan University Hospital. Belonging to a resource limited country, the opportunities to train in the discipline of Molecular Genetics are uncommon and infrequent.
Diagnostics North East is a new initiative to bring together the various research infrastructures, capabilities and resources that map to the development, research and innovation of diagnostic technologies available to both academic and commercial partners into a single cohesive structure.
This will lead to greater efficiencies, more visibility and greater opportunities to improve patient health and wellbeing through a common vision and a common approach.
The NIHR MICs, launched on 1 January 2018, have the remit of building expertise and capacity in the NHS to develop new medical technologies.
The NIHR Medtech and In vitro diagnostic Co-operatives (MICs) replace the NIHR Healthcare Technology Co-operatives (HTCs) and NIHR Diagnostic Evidence Co-operatives (DECs), incorporating and retaining the remits of both.
The CePa Biobank held their official launch event on the 19th January 2018. It was attended by colleagues from the NHS, Newcastle University, Industry collaborators as well as members of the public.
The CEPA Biobank has been created as a Trust initiative in response to requests from Commercial Companies and Researchers for access to a supply of good quality tissue for Quality Control/Assurance and Research purposes.
Sir Bobby Robson Foundation Patrons, Alan Shearer and Steve Harper, visited the Proximity Lab with Lady Elsie on the 22nd November to find out more about the PROSPECT-NE project. Please find out more information about the visit below and on the Chronicle’s website.
A revolutionary new ‘personalised’ cancer treatment and research project is being funded by the Sir Bobby Robson Foundation in Newcastle.